In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP‐505
2018
Background and Purpose
Targeting more than one opioid receptor type simultaneously may have analgesic advantages in reducing side‐effects. We have evaluated the mixed μ opioid receptor agonist/ δ opioid receptor antagonist UFP‐505 in vitro and in vivo.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
63
References
9
Citations
NaN
KQI